Allianz Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.3M | Sell |
34,339
-1,937
| -5% | -$903K | 0.02% | 705 |
|
|
2025
Q4 | $16.4M | Sell |
36,276
-73,885
| -67% | -$31.8M | 0.02% | 684 |
|
|
2025
Q3 | $43.1M | Sell |
110,161
-6,036
| -5% | -$2.52M | 0.05% | 374 |
|
|
2025
Q2 | $51.7M | Sell |
116,197
-24,888
| -18% | -$11.5M | 0.06% | 312 |
|
|
2025
Q1 | $68.4M | Sell |
141,085
-114,538
| -45% | -$53.4M | 0.09% | 215 |
|
|
2024
Q4 | $103M | Sell |
255,623
-3,262
| -1% | -$1.51M | 0.14% | 150 |
|
|
2024
Q3 | $120M | Sell |
258,885
-75,709
| -23% | -$36.4M | 0.17% | 125 |
|
|
2024
Q2 | $157M | Sell |
334,594
-49,484
| -13% | -$21.5M | 0.23% | 94 |
|
|
2024
Q1 | $161M | Sell |
384,078
-35,709
| -9% | -$15.1M | 0.25% | 88 |
|
|
2023
Q4 | $171M | Sell |
419,787
-58,972
| -12% | -$21.8M | 0.28% | 72 |
|
|
2023
Q3 | $166M | Sell |
478,759
-16,571
| -3% | -$5.8M | 0.28% | 63 |
|
|
2023
Q2 | $174M | Sell |
495,330
-291,644
| -37% | -$98.3M | 0.31% | 55 |
|
|
2023
Q1 | $248M | Sell |
786,974
-15,296
| -2% | -$4.59M | 0.44% | 40 |
|
|
2022
Q4 | $232M | Sell |
802,270
-78,484
| -9% | -$23.9M | 0.45% | 45 |
|
|
2022
Q3 | $255M | Sell |
880,754
-321,150
| -27% | -$92.4M | 0.52% | 33 |
|
|
2022
Q2 | $339M | Buy |
1,201,904
+529,249
| +79% | +$142M | 0.32% | 67 |
|
|
2022
Q1 | $176M | Buy |
672,655
+11,828
| +2% | +$2.81M | 0.13% | 168 |
|
|
2021
Q4 | $145M | Sell |
660,827
-8,617
| -1% | -$1.68M | 0.1% | 228 |
|
|
2021
Q3 | $121M | Buy |
669,444
+153,686
| +30% | +$30M | 0.09% | 231 |
|
|
2021
Q2 | $104M | Buy |
515,758
+105,558
| +26% | +$22.1M | 0.09% | 224 |
|
|
2021
Q1 | $88.1M | Buy |
410,200
+1,720
| +0.4% | +$378K | 0.09% | 239 |
|
|
2020
Q4 | $96.5M | Sell |
408,480
-383,244
| -48% | -$87.9M | 0.1% | 209 |
|
|
2020
Q3 | $215M | Sell |
791,724
-56,384
| -7% | -$15.6M | 0.25% | 85 |
|
|
2020
Q2 | $246M | Buy |
848,108
+39,339
| +5% | +$10.7M | 0.28% | 71 |
|
|
2020
Q1 | $192M | Sell |
808,769
-155,600
| -16% | -$35.7M | 0.26% | 89 |
|
|
2019
Q4 | $211M | Sell |
964,369
-495,910
| -34% | -$100M | 0.19% | 110 |
|
|
2019
Q3 | $247M | Sell |
1,460,279
-103,877
| -7% | -$18.4M | 0.24% | 80 |
|
|
2019
Q2 | $287M | Buy |
1,564,156
+92
| +0% | +$16.1K | 0.27% | 69 |
|
|
2019
Q1 | $288M | Sell |
1,564,064
-162,083
| -9% | -$29.9M | 0.28% | 66 |
|
|
2018
Q4 | $286M | Sell |
1,726,147
-35,845
| -2% | -$6.21M | 0.31% | 61 |
|
|
2018
Q3 | $340M | Buy |
1,761,992
+175,700
| +11% | +$31.3M | 0.31% | 60 |
|
|
2018
Q2 | $270M | Buy |
1,586,292
+193,487
| +14% | +$30M | 0.26% | 67 |
|
|
2018
Q1 | $227M | Buy |
1,392,805
+644,218
| +86% | +$105M | 0.22% | 91 |
|
|
2017
Q4 | $112M | Buy |
748,587
+27,001
| +4% | +$4M | 0.09% | 274 |
|
|
2017
Q3 | $110M | Buy |
721,586
+475,427
| +193% | +$71.6M | 0.09% | 251 |
|
|
2017
Q2 | $31.4M | Sell |
246,159
-84,109
| -25% | -$10.1M | 0.03% | 743 |
|
|
2017
Q1 | $35.9M | Sell |
330,268
-203,642
| -38% | -$17.9M | 0.04% | 666 |
|
|
2016
Q4 | $39.3M | Buy |
533,910
+184,452
| +53% | +$15M | 0.04% | 678 |
|
|
2016
Q3 | $30M | Sell |
349,458
-23,372
| -6% | -$2.21M | 0.03% | 741 |
|
|
2016
Q2 | $32.1M | Buy |
372,830
+34,062
| +10% | +$2.94M | 0.03% | 639 |
|
|
2016
Q1 | $26.9M | Buy |
338,768
+61,993
| +22% | +$5.61M | 0.03% | 638 |
|
|
2015
Q4 | $34.9M | Sell |
276,775
-113,367
| -29% | -$13.7M | 0.04% | 519 |
|
|
2015
Q3 | $40.6M | Sell |
390,142
-58,320
| -13% | -$7.49M | 0.05% | 460 |
|
|
2015
Q2 | $55.4M | Sell |
448,462
-252,256
| -36% | -$31.8M | 0.06% | 397 |
|
|
2015
Q1 | $82.7M | Sell |
700,718
-22,111
| -3% | -$2.65M | 0.09% | 226 |
|
|
2014
Q4 | $85.9M | Buy |
722,829
+224,408
| +45% | +$25.3M | 0.1% | 245 |
|
|
2014
Q3 | $56M | Buy |
498,421
+111,718
| +29% | +$10.6M | 0.07% | 337 |
|
|
2014
Q2 | $36.6M | Buy |
386,703
+42,824
| +12% | +$3M | 0.05% | 407 |
|
|
2014
Q1 | $24.3M | Buy |
343,879
+5,660
| +2% | +$448K | 0.03% | 499 |
|
|
2013
Q4 | $25.1M | Sell |
338,219
-98,965
| -23% | -$6.89M | 0.03% | 487 |
|
|
2013
Q3 | $33.1M | Sell |
437,184
-35,945
| -8% | -$2.86M | 0.04% | 418 |
|
|
2013
Q2 | $37.9M | Buy |
+473,129
| New | +$34.8M | 0.05% | 371 |
|
Other funds holding VRTX
VCM
VPM
Allianz Asset Management's VRTX Position: Q1 2026 in Review
Allianz Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 5.3% in Q1 2026, selling an estimated $903K and leaving 34,339 shares worth $15.3M. The position accounts for 0.02% of the portfolio, ranked #705.
Allianz Asset Management first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $340M in Q3 2018. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Allianz Asset Management held 34,339 shares of Vertex Pharmaceuticals worth $15.3M as of Q1 2026.
- Allianz Asset Management sold 1,937 Vertex Pharmaceuticals shares in Q1 2026, an estimated $903K.
- Vertex Pharmaceuticals made up 0.02% of Allianz Asset Management's portfolio in Q1 2026, its #705 holding.
- Allianz Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Vertex Pharmaceuticals position peaked at $340M in Q3 2018.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.